Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.
Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors.
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide. Lancet Oncol. 2006 May; 7(5):436-8.
View in:
PubMed
subject areas
Anemia, Aplastic
Antineoplastic Agents, Alkylating
Dacarbazine
Fatal Outcome
Glioblastoma
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Risk Factors
authors with profiles
Koen Van Besien